New York State Common Retirement Fund’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

New York State Common Retirement Fund’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-51,300	Closed	-$575K	–	3124
2017 Q3	$575K	Hold	51,300	–	–	﹤0.01%	2290
2017 Q2	$564K	Sell	51,300 -1	-0%	-$10	﹤0.01%	2351
2017 Q1	$503K	Sell	51,301 -3,699	-7%	-$36.9K	﹤0.01%	2379
2016 Q4	$594K	Sell	55,000 -16,319	-23%	-$163K	﹤0.01%	2297
2016 Q3	$731K	Buy	71,319 +7,700	+12%	+$83.9K	﹤0.01%	2142
2016 Q2	$831K	Buy	63,619 +3,579	+6%	+$46.9K	﹤0.01%	2048
2016 Q1	$660K	Sell	60,040 -1,513	-2%	-$13.5K	﹤0.01%	2141
2015 Q4	$566K	Sell	61,553 -14,308	-19%	-$120K	﹤0.01%	2255
2015 Q3	$526K	Buy	75,861 +23,360	+44%	+$200K	﹤0.01%	2294
2015 Q2	$516K	Buy	+52,501	New	+$478K	﹤0.01%	2504

New York State Common Retirement Fund's SCLN Position: Q4 2017 in Review

New York State Common Retirement Fund sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 51,300 shares — an estimated $575K sold.

New York State Common Retirement Fund first reported a position in SCLN in Q2 2015 and held it in 10 quarters. The position peaked at $831K in Q2 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

New York State Common Retirement Fund reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
New York State Common Retirement Fund sold 51,300 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $575K.
New York State Common Retirement Fund first reported a position in Sciclone Pharmaceuticals Inc in Q2 2015 and held it in 10 quarters.
New York State Common Retirement Fund's Sciclone Pharmaceuticals Inc position peaked at $831K in Q2 2016.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on New York State Common Retirement Fund's 13F filing for Q4 2017, filed 13 Feb 2018.